Single-peptide triple agonist of glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors for multi-pathway metabolic investigation. Synthesized under strict cGMP protocols. Validated with high-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS). For laboratory research use only.
Scan vial QR or input synthesis lot number.
GIP/GLP-1/GCGR
Single-peptide triple agonist of glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon (GCG) receptors for multi-pathway metabolic investigation. Synthesized under strict cGMP protocols. Validated with high-performance liquid chromatography (HPLC) and electrospray ionization mass spectrometry (ESI-MS). For laboratory research use only.
LifeNootropics enforces rigorous multi-stage HPLC and MS analytical standards across all synthesized batches. Providing verifiable fidelity to scientific institutions worldwide.
For in-vitro research use only. Not for human consumption.